Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001829126-26-001059·KALA BIO, Inc.
Schedule 13D ownership disclosure
KALA BIO INC
Common Stock, $0.001 par value · CUSIP: 483119202
Event date: 2026-01-30
- Filing-level shares
- 49,500,000.00
- Percent of class
- 5.18%
- David E. LazarReported CIK 0001932843
Shares: 49,500,000.00 · Class: 5.18%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001829126-26-001059
- Form type
- SCHEDULE 13D
- Filer
- KALA BIO, Inc.
- CIK
- CIK 1479419
- Filed
- Feb 06, 2026
- Reporting period
- Jan 30, 2026
- Description
- Schedule 13D beneficial ownership